A new study published in JAMA reveals that moderate coffee consumption may protect against atrial fibrillation (AFib), a common form of irregular heartbeat. Contrary to long-standing medical caution, researchers found that daily coffee drinkers had a significantly lower risk of AFib recurrence, offering fresh evidence for coffee’s heart-friendly potential.
Coffee’s Cardiovascular Comeback: Moderate Intake Linked to Lower AFib Risk
In a surprising twist to conventional wisdom, a new study led by researchers from the University of California, San Francisco and the University of Adelaide has found that moderate coffee consumption may reduce the risk of atrial fibrillation (AFib)—a condition affecting over 10 million Americans and millions more globally. Published on November 9, 2025, in the Journal of the American Medical Association (JAMA), the study challenges decades of medical advice that urged AFib patients to avoid caffeine.
Key Highlights from the DECAF Study:
39% Lower Risk of AFib Recurrence
Participants who drank coffee daily after AFib treatment were 39% less likely to experience a recurrence compared to those who abstained.
First Randomized Trial on Coffee and AFib
This marks the first randomized clinical trial investigating the link between caffeinated coffee and AFib outcomes, offering robust evidence beyond observational data.
Caffeine Not the Culprit
Researchers found that caffeine’s effects on activity, blood pressure, and inflammation may actually contribute to healthier heart rhythms, contradicting previous assumptions.
Doctors Rethinking Advice
Cardiologists like Dr. Gregory Marcus noted that many patients unnecessarily quit coffee due to outdated fears. The study suggests that moderate intake is not only safe but beneficial.
Practical Implications for Patients
For every six people who continued drinking coffee post-treatment, one additional person avoided AFib recurrence, making it a potentially impactful lifestyle choice.
Moderation Still Key
While the findings are promising, experts caution against excessive consumption and recommend 1–2 cups per day as a safe range for most adults.
This research repositions coffee from a potential cardiac risk to a protective ally, especially for those managing AFib. It underscores the importance of evidence-based guidance in shaping lifestyle recommendations.
Sources: Hindustan Times, Daily Coffee News, Yahoo News